(Q43013129)

12 November 2017

title

Prognostic value of IDH1 mutations identified with PCR-RFLP assay in glioblastoma patients (English)

1 reference

12 November 2017

1 reference

7

Wiesław Bonicki

1 reference

12 November 2017

2

Paulina Kober

1 reference

12 November 2017

8

Janusz A Siedlecki

1 reference

12 November 2017

1

Mateusz Bujko

1 reference

12 November 2017

3

Ewa Matyja

1 reference

12 November 2017

4

Paweł Nauman

1 reference

12 November 2017

author name string

Katarzyna Dyttus-Cebulok

series ordinal

5

1 reference

12 November 2017

Beata Czeremszyńska

series ordinal

6

1 reference

12 November 2017

publication date

1 June 2010

1 reference

Molecular Diagnosis and Therapy

12 November 2017

published in

1 reference

12 November 2017

volume

14

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

163-169

1 reference

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Genetic pathways to primary and secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Expression and mutagenesis of mammalian cytosolic NADP+-specific isocitrate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Genotypic selection methods for the direct analysis of point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

PCR- and restriction endonuclease-based detection of IDH1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256369

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20560678

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF03256369

1 reference

12 November 2017

1 reference